Company Overview

Company Profile

Enveric Biosciences (NASDAQ: ENVB) is leveraging their discovery engine and intellectual property portfolio to identify and build the next generation of psychedelic and cannabinoid medicines for the mind and body. By harnessing the power of synthetic biology and chemistry, the company is taking what Nature created and optimizing it for the Human Condition. Enveric's robust pipeline supports drug development from the clinic to commercialization for millions of patients in need around the world suffering from cancer-related distress, PTSD and more.

Corporate Presentation

Featured Event

MagicMed Industries Acquisition Conference Call

  • Date: May 24, 2021 at 8:30 AM ET
  • Webcast: Register

Stock Quote